Cadre (NYSE:CDRE – Get Rating) and Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Rating) are both small-cap industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, valuation, analyst recommendations, dividends and institutional ownership.
Insider & Institutional Ownership
34.1% of Cadre shares are held by institutional investors. 52.9% of Cadre shares are held by insiders. Comparatively, 34.1% of Advanced Biomedical Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Get
Cadre alerts:
Profitability
This table compares Cadre and Advanced Biomedical Technologies' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
| Cadre | 0.80% | 3.86% | 1.36% |
| Advanced Biomedical Technologies | N/A | N/A | N/A |
Analyst Ratings
This is a summary of current recommendations for Cadre and Advanced Biomedical Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| Cadre | 0 | 0 | 4 | 0 | 3.00 |
| Advanced Biomedical Technologies | 0 | 0 | 0 | 0 | N/A |
Cadre presently has a consensus target price of $32.80, suggesting a potential upside of 38.69%. Given Cadre's higher possible upside, analysts plainly believe Cadre is more favorable than Advanced Biomedical Technologies.
Risk & Volatility
Cadre has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500.
Valuation and Earnings
This table compares Cadre and Advanced Biomedical Technologies' revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| Cadre | $427.29 million | 2.07 | $12.66 million | $0.08 | 295.66 |
| Advanced Biomedical Technologies | $120,000.00 | 34.86 | -$670,000.00 | N/A | N/A |
Cadre has higher revenue and earnings than Advanced Biomedical Technologies.
Summary
Cadre beats Advanced Biomedical Technologies on 10 of the 11 factors compared between the two stocks.
About Cadre
(Get Rating)
Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies. The company was founded in 1964 and is headquartered in Jacksonville, Florida.
About Advanced Biomedical Technologies
(Get Rating)
Advanced BioMedical Technologies, Inc. engages in the provision of medical and pain management tools. Its products include Electro-Acuscope 85P (Portable), Electro-Acuscope 80L, Neuroscope 230B, Electro-Myopulse 75L (Base Model), Electro-Myopulse 75F (Used in Fermi Lab Study), and Electro-Myopulse EMS 85P (Portable). The company was founded in 1984 and is headquartered in New York, NY.
Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.
